Literature DB >> 7120016

Evidence for bipolar mood states.

M Lorr, D M McNair, S U Fisher.   

Abstract

Currently, the mood states are regarded as monopolar. This study tested in psychiatric subjects for the presence of five bipolar mood states after the influence of extreme response bias had been removed. The affective states hypothesized were: composed vs anxious, agreeable vs hostile, energetic vs fatigued, elated vs depressed, and clear-thinking vs confused. The sample of 303 cases included anxious, depressed and agoraphobic cases. Ratings of the 72 adjectives of the Profile of Mood States were intercorrelated. After extreme response bias score was partialled out the resulting correlations were analyzed by the method of principal components. The five factors isolated clearly support the bipolar nature of mood states postulated.

Entities:  

Mesh：

Year:  1982        PMID： 7120016     DOI： 10.1207/s15327752jpa4604_16

Source DB:  PubMed          Journal:  J Pers Assess        ISSN： 0022-3891


  25 in total

1.  A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Authors:  Marco Leyton; Valerie Kwai Pun; Chawki Benkelfat; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 2.  Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.

Authors:  Annette J Thomas; Rita Ismail; Lisa Taylor-Swanson; Lori Cray; Janet G Schnall; Ellen Sullivan Mitchell; Nancy Fugate Woods
Journal:  Maturitas       Date:  2014-05-28       Impact factor: 4.342

3.  Differences between males and females in rates of serotonin synthesis in human brain.

Authors:  S Nishizawa; C Benkelfat; S N Young; M Leyton; S Mzengeza; C de Montigny; P Blier; M Diksic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Systematic manipulations of the biological stress systems result in sex-specific compensatory stress responses and negative mood outcomes.

Authors:  Nida Ali; Jonas P Nitschke; Cory Cooperman; Mark W Baldwin; Jens C Pruessner
Journal:  Neuropsychopharmacology       Date:  2020-06-04       Impact factor: 7.853

5.  Thyroid hormones and cognitive functioning in healthy, euthyroid women: a correlational study.

Authors:  Miglena Grigorova; Barbara B Sherwin
Journal:  Horm Behav       Date:  2012-02-20       Impact factor: 3.587

6.  Methyl mercury exposure and neurodevelopmental outcomes in the Seychelles Child Development Study Main cohort at age 22 and 24years.

Authors:  Edwin van Wijngaarden; Sally W Thurston; Gary J Myers; Donald Harrington; Deborah A Cory-Slechta; J J Strain; Gene E Watson; Grazyna Zareba; Tanzy Love; Juliette Henderson; Conrad F Shamlaye; Philip W Davidson
Journal:  Neurotoxicol Teratol       Date:  2016-10-28       Impact factor: 3.763

7.  Acute and repetitive fronto-cerebellar tDCS stimulation improves mood in non-depressed participants.

Authors:  Simon Newstead; Hayley Young; David Benton; Gabriela Jiga-Boy; Maria L Andrade Sienz; R M Clement; Frédéric Boy
Journal:  Exp Brain Res       Date:  2017-11-02       Impact factor: 1.972

8.  Research and training in biological psychiatry: where are the clinical psychology techniques?

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

9.  Prenatal methyl mercury exposure in relation to neurodevelopment and behavior at 19 years of age in the Seychelles Child Development Study.

Authors:  E van Wijngaarden; S W Thurston; G J Myers; J J Strain; B Weiss; T Zarcone; G E Watson; G Zareba; E M McSorley; M S Mulhern; A J Yeates; J Henderson; J Gedeon; C F Shamlaye; P W Davidson
Journal:  Neurotoxicol Teratol       Date:  2013-06-14       Impact factor: 3.763

10.  Effects of diazepam on facial emotion recognition.

Authors:  Nick J Coupland; Anita J Singh; Ryan A Sustrik; Patricia Ting; R Blair
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.